secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001493152-25-018324
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio regains Nasdaq minimum bid price compliance; reports $133.3M cash
------------------------------------------------------------------------------

- Received Nasdaq compliance letter confirming regained bid price requirement; matter closed as of Oct 15, 2025.
- Cash and cash equivalents approx. $133.3 million as of Oct 15, 2025.
- Outstanding common shares: 133,002,572; pre-funded warrants for 73,271,424 shares.
- No other material corporate updates provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225018324/0001493152-25-018324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225018324/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer